How long does it take for the final dose of synthetic LT3 (Liothyronine) hormone to clear from blood, and how much suffering might a withdrawal cause? This is an important question for many people who dose LT3. They want to… Read More ›
Thyroid therapy
Acella NP Thyroid recall: maternal risk inflated
Acella, the makers of NP Thyroid, issued a voluntary recall notice on May 22, 2020. This is part 2 of a two-part series reviewing the drug recall notice’s statements and the science behind them. [Part 1: Acella NP Thyroid recall:… Read More ›
Acella NP Thyroid recall: Ethical yet low-risk
Acella, the makers of NP Thyroid, issued a voluntary recall notice on May 22, 2020. This is part 1 of a two-part series reviewing the drug recall notice’s statements and the science behind them. In this post, I put this… Read More ›
Review: Hoang’s 2013 conversion table for desiccated thyroid
Please circulate this widely to help science win the upper hand over rigid opinions. The table shown above is a clinical research-based pharmaceutical conversion estimate. It’s from Hoang et al’s 2013 randomized clinical trial comparing NDT (desiccated thyroid extract, DTE)… Read More ›
Four definitions of thyroid status
We have a definition problem in thyroid science and thyroid therapy. A lot of confusion stems from the many definitions the words “euthyroidism,” “hypothyroidism” and “hyperthyroidism.” These are terms that can be defined in many ways by doctors, patients, and… Read More ›
Japanese thyroid scientists examine symptoms in relation to FT3 and TSH
I would like to applaud a 2019 article by Mitsuru Ito and colleagues from the Center for Excellence in Thyroid Care at Kuma Hospital, Kobe, Japan. Dear researchers, your article, “Thyroid function related symptoms during monotherapy in athyreotic patients” showcased… Read More ›
Biochemical bigotry: Enforcing normalized thyroid lab results
Valentine’s day is a good day to attempt to promote kindness and tolerance toward people suffering from a rather invisible health condition. Thyroid disease. What better day than today to identify and attempt to remove a medical attitude that is… Read More ›
New clinical trial of Armour Thyroid is recruiting U.S. patients
A clinical trial comparing Armour Thyroid (NDT) and Levothyroxine (LT4) is now recruiting patients in the United States. The sponsor of the study is Allergan, the makers of Armour Thyroid in the United States. They hope to recruit 220 patients… Read More ›